CoChat

Bezafibrate lowers very long‐chain fatty acids in X‐linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation

Open access
Engelen, Marc, Schackmann, Martin J. A., Ofman, Rob, Sanders, Robert‐Jan, Dijkstra, Inge M. E., Houten, Sander M., Fourcade, Stéphane, Pujol, Aurora, Poll‐The, Bwee Tien, Wanders, Ronald J. A., Kemp, Stephan · 2012 · Journal of Inherited Metabolic Disease
Cited by 48

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

X‐linked adrenoleukodystrophy (X‐ALD) is caused by mutations in the ABCD1 gene encoding ALDP, an ATP‐binding‐cassette (ABC) transporter located in the peroxisomal membrane. ALDP deficiency results in impaired peroxisomal β‐oxidation and the subsequent accumulation of very long‐chain fatty acids (VLCFA; > C22:0) in plasma and tissues. VLCFA are primarily derived from endogenous synthesis by ELOVL1. Therefore inhibiting this enzyme might constitute a feasible therapeutic approach. In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X‐ALD fibroblasts. Surprisingly, the VLCFA‐lowering effect was independent of PPAR activation and not caused by the increase in either mitochondrial or peroxisomal fatty acid β‐oxidation capacity. In fact, our results show that bezafibrate reduces VLCFA synthesis by decreasing the synthesis of C26:0 through a direct inhibition of fatty acid elongation activity. Taken together, our data indicate bezafibrate as a potential pharmacotherapeutic treatment for X‐ALD. A clinical trial is currently ongoing to evaluate the effect in patients with X‐ALD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10545-012-9471-4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Engelen, M., Schackmann, M. J. A., Ofman, R., Sanders, R., Dijkstra, I. M. E., Houten, S. M., Fourcade, S., Pujol, A., Poll‐The, B. T., Wanders, R. J. A., & Kemp, S.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2012-03-24
Volume
35
Issue
6
Pages
1137-1145
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2052147460
Cited by
48
References
14
FWCI
2.33
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.